InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,129.81
(
1.30%
)
US TECH 100
17,421.80
(
2.03%
)
Dow Jones
38,668.57
(
1.16%
)
Brent Oil
82.79
(
-1.01%
)
Bitcoin
61,656.17
(
4.29%
)
Post# of 251699
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12425
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Friday, 02/05/2016 7:38:43 PM

Friday, February 05, 2016 7:38:43 PM

Post# of 251699
Remicade, Humira and Enbrel work by blocking an inflammation-causing protein called Tumor Necrosis factor (TNF). Raymond said more than 60 other anti-TNF biosimilars are in development and could commoditize the drug class much sooner than thought.

https://www.yahoo.com/news/fda-reviewers-support-celltrions-biosimilar-remicade-125940029--finance.html

Amazingly, this appears to be following the steel industry..
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up